Aug 3 (Reuters) – CVS Health Corp on Wednesday raised its full-year profit forecast after strength in its insurance business and sales of COVID-19 over-the-counter test kits helped the company report a 6% jump in second-quarter earnings.

The largest U.S. pharmacy chain’s retail and long-term care segment revenue rose 6.3%, helped by the sale of OTC test kits and the impact of the flu season, which helped offset lower COVID-19 vaccinations and diagnostic testing.

Its insurance business reported an 11% growth in revenue as well as a decrease in medical benefit ratio, which is the costs it incurs as a percentage of premiums.

CVS raised its adjusted profit outlook how to buy clomid $8.40-$8.60 per share from $8.20-$8.40 per share forecast earlier.

Net income for the quarter ended June 30 rose how to buy clomid $2.96 billion, or $2.23 per share, from $2.79 billion, or $2.10 per share a year earlier. (By Leroy Leo and Bhanvi Satija in Bengaluru; Editing by Vinay Dwivedi)

In case you loved this short article and you would want how to buy clomid receive more information concerning cost of generic clomid generously visit our own page.